A recently published report has revealed that less than 13 per cent of US consumers believe that information provided by pharmaceutical companies is more trustworthy than healthcare information provided by other organisations.
Other glimpses of the bleeding obvious in the report confirm what most industry analysts, including Insider, have long been saying. The Vioxx case, along with safety concerns over other blockbusters, have all but sounded the death knell on Big Pharmas' fragile reputation.
The stables need a good cleaning.
"The new research also finds that public opinion has the potential to negatively impact individual pharmaceutical companies far more dramatically than increased federal regulations," said Datamonitor eHealth analyst Kimberly O'Malley.
"In fact many consumers now question whether pharmaceutical companies have their best interests in mind when marketing a product."
Well blow me down!
Insiders' view: If you buy the report then come see me, I've got a great offer on a bridge!
No comments:
Post a Comment